Calendar

Week of Apr 27, 2026

Apr 28, 2026phase 1 completion91d agoInternational Bio Service Co Ltd — Bisoprolol fumarate (Phase I Trial Completion)BISOPROLOL FUMARATE

Therapy area: Cardiovascular. Indication: Hypertension

full page →BISOPROLOL FUMARATE →source: globaldata

Apr 28, 2026phase 1 completion91d agoPolfa Tarchomin SA — empagliflozin (Phase I Trial Completion)SYNJARDY

Therapy area: Cardiovascular, Metabolic Disorders. Indication: Congestive Heart Failure (Heart Failure), Type 2 Diabetes

full page →SYNJARDY →source: globaldata

Apr 28, 2026phase 2 completion91d agoUniversity of Sao Paulo General Hospital — iloprost (Phase II Trial Completion)iloprost

Therapy area: Cardiovascular. Indication: Pulmonary Arterial Hypertension

full page →iloprost →source: globaldata

Apr 29, 2026phase 1 completion90d agoUniversity of Washington — autologous mitochondria (Phase I Trial Completion)autologous mitochondria

Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia

full page →autologous mitochondria →source: globaldata

Apr 29, 2026phase 1 initiation90d agoBayer AG — asundexian (Phase I Trial Initiation)asundexian

Therapy area: Cardiovascular. Indication: Ischemic Stroke

full page →asundexian →source: globaldata

Apr 29, 2026phase 2 initiation90d agoSawai Man Singh Medical College — phenylephrine (Phase II Trial Initiation)phenylephrine

Therapy area: Cardiovascular. Indication: Hypotension

full page →phenylephrine →source: globaldata

Apr 30, 2026constraining patent expiry europe89d agoCumberland Pharmaceuticals Inc — telavancin hydrochloride (Constraining Patent Expiry (Europe))telavancin hydrochloride

Therapy area: Cardiovascular, Dermatology, Infectious Disease, Respiratory. Indication: Anthrax, Bacteremia, Bacterial Endocarditis, Bacterial Pneumonia, Complicated Skin And Skin Structure Infections (cSSSI), Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections, Hospital Acquired Pneumonia (HAP), Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Skin And Soft Tissue Infections, Ventilator Associated Pneumonia (VAP)

full page →telavancin hydrochloride →source: globaldata

Apr 30, 2026phase 0 trial completion89d agoCivil Aviation General Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

Therapy area: Cardiovascular, Respiratory. Indication: Ischemia Reperfusion Injury, Lung Disease

full page →dexmedetomidine →source: globaldata

Apr 30, 2026phase 0 trial completion89d agoHefei First People’s Hospital — ergothioneine (Phase 0 Trial Completion)ergothioneine

Therapy area: Cardiovascular. Indication: Atherosclerosis

full page →ergothioneine →source: globaldata

Apr 30, 2026phase 0 trial completion89d agoKey Projects of Science and Technology Department of Sichuan Province — dantrolene (Phase 0 Trial Completion)dantrolene

Therapy area: Cardiovascular. Indication: Ischemia, Myocardial Ischemia, Ventricular Arrhythmia

full page →dantrolene →source: globaldata

Apr 30, 2026phase 0 trial completion89d agoInner Mongolia Aerospace Hospital — (bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) (Phase 0 Trial Completion)(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12)

Therapy area: Cardiovascular, Gastrointestinal. Indication: Atherosclerosis, Irritable Bowel Syndrome

full page →(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) →source: globaldata

Apr 30, 2026phase 1 completion89d agoJiangxi Jemincare Group Co Ltd — JMKX-003142 (Phase I Trial Completion)JMKX-003142

Therapy area: Cardiovascular, Genetic Disorders. Indication: Edema, Polycystic Kidney Disease

full page →JMKX-003142 →source: globaldata

Apr 30, 2026phase 1 completion89d agoJiangsu Postgraduate Research and Practice Innovation Program — acetaminophen (Phase I Trial Completion)acetaminophen ER

Therapy area: Cardiovascular. Indication: Patent Ductus Arteriosus

full page →acetaminophen ER →source: globaldata

Apr 30, 2026phase 1 completion89d agoPhrae Hospital — bupivacaine (Phase I Trial Completion)bupivacaine

Therapy area: Cardiovascular, Central Nervous System, Gastrointestinal. Indication: Hypotension, Post Operative Nausea And Vomiting, Post-Operative Pain

full page →bupivacaine →source: globaldata

Apr 30, 2026phase 1 completion89d agoBarts Charity — undisclosed Covid-19 vaccine (Phase I Trial Completion)undisclosed Covid-19 vaccine

Therapy area: Cardiovascular. Indication: Cardiovascular Disease, Endothelial Dysfunction

full page →undisclosed Covid-19 vaccine →source: globaldata

Apr 30, 2026phase 1 initiation89d agoEgyptian International Pharmaceuticals Industries Co SAE — enoxaparin sodium biosimilar (Phase I Trial Initiation)enoxaparin sodium biosimilar

Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Congestive Heart Failure (Heart Failure), Deep Vein Thrombosis (DVT), Myocardial Infarction, Pulmonary Embolism, Thromboembolic Disease, Thromboembolism, Thrombosis, Unstable Angina, Venous (Vein) Thrombosis, Venous Thromboembolism

full page →enoxaparin sodium biosimilar →source: globaldata

Apr 30, 2026phase 1 initiation89d agoFirst Affiliated Hospital of Bengbu Medical University — Loberamisal (Phase I Trial Initiation)Loberamisal

Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke

full page →Loberamisal →source: globaldata

Apr 30, 2026phase 1 initiation89d agoBio-Innova Co Ltd — dapagliflozin (Phase I Trial Initiation)DAPAGLIFLOZIN

Therapy area: Cardiovascular, Genito Urinary System, Metabolic Disorders. Indication: Cardiovascular Risk Factors, Diabetic Nephropathy, Type 1 Diabetes (Juvenile Diabetes), Type 2 Diabetes

full page →DAPAGLIFLOZIN →source: globaldata

Apr 30, 2026phase 1 2 completion89d agoDuke University — deferiprone (Phase I/II Trial Completion)deferiprone

Therapy area: Cardiovascular, Central Nervous System. Indication: Cerebral Aneurysms, Dementia, Stroke, Subarachnoid Hemorrhage

full page →deferiprone →source: globaldata

Apr 30, 2026phase 1 2 completion89d agoImplicit Bioscience Ltd — Atibuclimab (Phase I/II Trial Completion)Atibuclimab

Therapy area: Cardiovascular. Indication: Acute Decompensated Heart Failure, Congestive Heart Failure (Heart Failure)

full page →Atibuclimab →source: globaldata

Apr 30, 2026phase 2 completion89d agoGerman Sport University Cologne — polyphenol-rich cocoa extract (Phase II Trial Completion)polyphenol-rich cocoa extract

Therapy area: Cardiovascular. Indication: Idiopathic (Essential) Hypertension

full page →polyphenol-rich cocoa extract →source: globaldata

Apr 30, 2026phase 2 completion89d agoMedanta - The Medicity — centhaquine citrate (Phase II Trial Completion)centhaquine citrate

Therapy area: Cardiovascular, Other Diseases. Indication: Hemorrhagic Shock, Injury, Trauma

full page →centhaquine citrate →source: globaldata

Apr 30, 2026phase 2 completion89d agoCancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)lenvatinib

Therapy area: Cardiovascular, Oncology. Indication: Hepatocellular Carcinoma, Thrombosis, Venous (Vein) Thrombosis

full page →lenvatinib →source: globaldata

Apr 30, 2026phase 2 completion89d agoMedical University of Gdansk — apixaban (Phase II Trial Completion)apixaban ODT

Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism

full page →apixaban ODT →source: globaldata

Apr 30, 2026phase 2 completion89d agoNeurodawn Pharmaceutical Co Ltd — Loberamisal (Phase II Trial Completion)Loberamisal

Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Cerebral Infarction (Brain Infarction)

full page →Loberamisal →source: globaldata

Apr 30, 2026phase 2 completion89d agoSohag University — ephedrine (Phase II Trial Completion)ephedrine

Therapy area: Cardiovascular. Indication: Hypotension

full page →ephedrine →source: globaldata

Apr 30, 2026phase 2 completion89d agoNational Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)metformin hydrochloride ER

Therapy area: Cardiovascular, Genito Urinary System, Infectious Disease. Indication: Acute Renal Failure (ARF) (Acute Kidney Injury), Sepsis, Septic Shock

full page →metformin hydrochloride ER →source: globaldata

Apr 30, 2026phase 2 completion89d agoCurtin University — influenza vaccine (Phase II Trial Completion)influenza vaccine

Therapy area: Cardiovascular. Indication: Myocardial Infarction

full page →influenza vaccine →source: globaldata

Apr 30, 2026phase 2 completion89d agoDutch Heart Foundation — ghrelin (Phase II Trial Completion)ghrelin

Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Ischemic Stroke

full page →ghrelin →source: globaldata

Week of Apr 27, 2026